Is EXC stock a buy or a sell according to analysts?

Of the 37 analyst ratings on Exelon Corporation, 38% are Buy or Strong Buy, 22 are Hold, and 1 are Sell. The overall consensus rating is Hold. Analyst ratings are opinions, not investment advice.

What is the analyst price target for EXC?

The average analyst price target for Exelon Corporation is $46.40. Individual targets range from $41.00 to $50.00.

When is Exelon Corporation's next earnings date?

Exelon Corporation is scheduled to report earnings on October 30, 2026. Analysts expect earnings of $0.78 per share.

Does Exelon Corporation pay a dividend?

Yes — Exelon Corporation has paid $1.66 per share in dividends over the trailing twelve months.

How volatile is EXC stock?

EXC has a beta of 0.40, meaning it has historically been less volatile than the broader market.

What sector is Exelon Corporation in?

Exelon Corporation operates in the Utilities sector, the Regulated Electric industry, and its stock trades on NASDAQ.

Back to Markets

Open EXC on Vela

Exelon Corporation

EXC

0.00

USD

+0.00+0.00%

Overview Financials News Trades Technicals Forecast Transcripts

Exelon Corporation at a glance

Open EXC on Vela

Exelon Corporation (EXC) is an Utilities company in the Regulated Electric industry, headquartered in Chicago, IL, with about 20,571 employees. Its shares trade on NASDAQ, and its IPO date is May 2, 1973. With a market capitalization of $45.8 billion, EXC is a large-cap stock.

It trades an average of 8.0 million shares a day.

In its latest reported quarter (results released July 30, 2026), Exelon Corporation posted revenue of $6.0 billion and earnings of $0.43 per share, against estimates of $5.4 billion and $0.44.

Figures as of October 26, 2026, from market data providers. Descriptive only, not financial advice.

EXC: Frequently asked questions

As of October 26, 2026, Exelon Corporation has a market capitalization of $45.8 billion, making it a large-cap company in the Utilities sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.